| 1.是否在募集资金到位后一个月内签订三方监管协议 | 是 | | | --- | --- | --- | | 2.募集资金三方监管协议是否有效执行 | 是 | | | 3.募集资金是否不存在第三方占用或违规进行委托理财等情形 | 是 | | | 4.是否不存在未履行审议程序擅自变更募集资金用途、暂时补充流动 | 是 | | | 资金、置换预先投入、改变实施地点等情形 | | | | 5.使用闲置募集资金暂时补充流动资金、将募集资金投向变更为永久 | | | | 性补充流动资金或者使用超募资金补充流动资金或者偿还银行贷款 | | 不适用 | | 的，公司是否未在承诺期间进行风险投资 | | | | 是 | | | | 6.募集资金使用与已披露情况是否一致，项目进度、投资效益是否与 （注 | | | | 招股说明书等相符 | ） | | | 7.募集资金项目实施过程中是否不存在重大风险 | 是 | | | 注：公司募集资金使用与已披露情况一致，公司已于 2025 年 4 月 21 日披露募集资金投资项目 | | | | 延期及部分项目新增实施地点的公告 | | | | （六）业绩情况 | | | | 现场检查 ...

东吴证券股份有限公司 关于江苏华阳智能装备股份有限公司 持续督导培训情况报告书 东吴证券股份有限公司（以下简称"东吴证券"或"保荐人"）作为江苏 华阳智能装备股份有限公司（以下简称"华阳智能"或"公司"）首次公开发 行股票并在创业板上市及持续督导的保荐人，根据《深圳证券交易所创业板股 票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》 等法规和规则的相关规定以及华阳智能的实际情况，认真履行保荐人应尽的职 责，对华阳智能的董事、监事、高级管理人员、公司控股股东和实际控制人等 相关人员进行了有计划、多层次的后续培训，所培训的内容严格按照中国证券 监督管理委员会及深圳证券交易所有关持续督导的最新要求进行。 2025 年 12 月 30 日，东吴证券相关人员按照《深圳证券交易所上市公司自 律监管指引第 13 号——保荐业务》的要求完成了对华阳智能相关人员的持续培 训工作，特向贵所报送培训工作报告。 一、培训基本情况 培训期间，接受培训人员认真配合保荐人的培训工作，并积极进行交流沟通， 保证了本次培训的顺利开展。通过本次 ...

Core Viewpoint - The company reported a decline in revenue and net profit for the first three quarters of 2025, but showed significant growth in net profit for the third quarter, indicating potential recovery and strategic focus on key business areas [1]. Financial Performance - The company achieved an operating income of 318 million yuan for the first three quarters of 2025, a decrease of 14.52% compared to the same period last year [1]. - The net profit attributable to shareholders was 24.6 million yuan, down 2.38% year-on-year [1]. - In the third quarter alone, the net profit attributable to shareholders increased by 61.24% year-on-year, while the net profit excluding non-recurring items grew by 107.84% [1]. Business Development - The company focuses on two main business segments: micro-special motors and components, and precision drug delivery devices [1]. - In the micro-special motors and components segment, the company is enhancing its market presence by deepening relationships with existing clients and actively seeking new customers, while also shifting towards higher-end industry fields [1]. - The company is accelerating the automation and intelligent production transformation of micro-special motors to reduce costs and improve product competitiveness [1]. - In the precision drug delivery devices segment, the company is strengthening collaboration with existing strategic clients, increasing customer loyalty, and actively engaging with new clients, with several customized projects entering the testing and validation phase [1].

Core Viewpoint - The company, Huayang Intelligent, aims to achieve growth through a dual-driven strategy and diversified performance growth points, focusing on precision motors and medical devices as key areas for development [1] Group 1: Strategic Goals - The overall operational goal is to strengthen the precision motor segment and become an industry leader in medical devices [1] - The strategic direction emphasizes deep layout and collaborative development in the micro-special motor and healthcare sectors [1] Group 2: Development Strategy - The company plans to consolidate its existing core business and enhance the market competitiveness of its micro-special motors and components [1] - There is a commitment to driving business development through technological innovation, particularly in the precision drug delivery device sector [1] - The company aims to expand the application of motor products into emerging areas such as smart home, automotive, and robotics, establishing a diversified strategic blueprint centered on micro-special motors and healthcare [1]

Core Viewpoint - Huayang Intelligent has established itself as a significant player in the micro-special motor and component sector, with a strong reputation and stable market share, particularly in the air conditioning segment [1] Group 1: Micro-special Motors and Components - The company has developed a high level of industry expertise over the years and serves major clients such as Midea, Gree, Haier, Hisense, and Aux [1] - The market demand for micro-special motors is expected to increase due to the home appliance industry's shift towards high-end, integrated, and intelligent products, as well as the expansion of the central air conditioning market [1] Group 2: Precision Drug Delivery Devices - In the precision drug delivery device sector, the company is one of the earliest entrants in China and holds a leading position with a comprehensive product line [1] - Major clients include domestic and international biopharmaceutical companies such as Jinsai Pharmaceutical, Haosen Pharmaceutical, and Corning Jereh [1] - The company's products have successfully adapted to various drug delivery needs, including recombinant human growth hormone and insulin, and are continuously exploring applications for new drug types [1] - The precision drug delivery device business is anticipated to enter a phase of accelerated growth due to the steady increase in the market for existing applicable drugs and the ongoing development of new drug applications [1]

Group 1: Financial Performance - In the first three quarters of 2025, the company achieved an operating income of 318 million yuan, a decrease of 14.52% compared to the same period last year [2] - The net profit attributable to shareholders was 24.6 million yuan, down 2.38% year-on-year [3] - In Q3, the net profit attributable to shareholders increased by 61.24% year-on-year, and the non-recurring net profit grew by 107.84% [3] Group 2: Business Development - The company focuses on two main sectors: micro-special motors and precision drug delivery devices [3] - In the micro-special motors sector, the company is enhancing its market presence by deepening relationships with existing clients and actively seeking new customers [3] - In the precision drug delivery device sector, the company is strengthening cooperation with strategic clients and has multiple customized projects in the testing and validation stages [4] Group 3: Industry Position - The company has established itself as a significant player in the micro-special motors and components industry, with a stable market share and notable clients such as Midea, Gree, and Haier [4] - In the precision drug delivery device market, the company is a leading domestic manufacturer, serving major pharmaceutical companies and adapting its products for various drug delivery needs [4] Group 4: Future Growth Strategy - The company aims to enhance operational efficiency and profitability while seeking synergistic acquisition targets to achieve technological upgrades and market expansion [6] - The growth model is based on a dual-driven strategy focusing on micro-special motors and healthcare, with an emphasis on consolidating existing business and expanding into new applications [6] - The strategic blueprint includes deepening the market presence in micro-special motors and medical devices while exploring new applications in smart homes, automotive, and robotics [6]

证券代码：301502 证券简称：华阳智能 公告编号：2025-054 江苏华阳智能装备股份有限公司 关于特定股东、董事、高级管理人员股份减持计划期限届满暨 实施结果的公告 公司董事於建东先生、董事兼副总经理王少锋先生、特定股东俞贤萍女士保证 向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大 遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 江苏华阳智能装备股份有限公司（以下简称"公司"）于2025年9月 8日披露了《关于特定股东、董事、高级管理人员减持股份的预披露公告》 （公告编号：2025-049）。因个人资金需求，公司董事於建东先生、董事 兼副总经理王少锋先生及特定股东俞贤萍女士分别计划在上述预披露公告 披露之日起十五个交易日后的三个月内（2025年9月29日至2025年12月28日） 以集中竞价或大宗交易方式减持不超过171,250股、68,500股、256,875股。 公司于近日收到了董事於建东先生、董事兼副总经理王少锋先生及特 定股东俞贤萍女士出具的《关于股份减持计划期限届满的告知函》，截至 2025年12月28日，前述股东的本次减持计划期限已届满， ...

Market Performance - The electric motor sector increased by 0.9% compared to the previous trading day, with Huayang Intelligent leading the gains [1] - The Shanghai Composite Index closed at 3940.95, up 0.53%, while the Shenzhen Component Index closed at 13486.42, up 0.88% [1] Stock Performance - Huayang Intelligent (301502) closed at 44.19, with a rise of 2.27% and a trading volume of 6007.13 lots, amounting to 26.40 million yuan [1] - Weiguang Co. (002801) closed at 33.96, up 2.14%, with a trading volume of 22,200 lots and a turnover of 75.11 million yuan [1] - Xiangming Intelligent (301226) closed at 31.70, increasing by 1.99%, with a trading volume of 78,800 lots and a turnover of 256 million yuan [1] - Other notable stocks include Benrui Co. (300626) at 14.31 (+1.92%), Shenli Co. (618809) at 11.41 (+1.78%), and Dongyang Electric (002249) at 10.29 (+1.68%) [1] Capital Flow - The electric motor sector experienced a net outflow of 250 million yuan from main funds, while retail investors saw a net inflow of 287 million yuan [2] - The detailed capital flow indicates that Jiadian Co. (000922) had a main fund net inflow of 17.77 million yuan, while it faced a retail net outflow of 25.08 million yuan [3] - Shenli Co. (603813) had a main fund net inflow of 6.99 million yuan but also saw a retail net outflow of 6.20 million yuan [3]

Core Viewpoint - Huayang Intelligent (301502.SZ) is focusing its R&D efforts on frameless motor technology, with ongoing progress in the project and an emphasis on market application and customer demand assessment [1] R&D Progress - The company is advancing its frameless motor R&D project in an orderly manner [1] - There has not yet been a realization of product mass production [1] Market Application - The company is continuously monitoring the market applications of related products [1] - Customer demand is being evaluated to align with the development of the technology [1]

Market Overview - The electric motor sector experienced a decline of 1.15% on the previous trading day, with Xiangming Intelligent leading the drop [1] - The Shanghai Composite Index closed at 3876.37, up 0.16%, while the Shenzhen Component Index closed at 13053.98, down 1.29% [1] Stock Performance - Notable gainers in the electric motor sector included: - Shenli Co., Ltd. (Code: 618809) with a closing price of 10.94, up 1.96% [1] - Huayang Intelligent (Code: 301502) with a closing price of 42.87, up 1.16% [1] - Kangping Technology (Code: 300907) with a closing price of 28.61, up 0.74% [1] - Major decliners included: - Xiangming Intelligent (Code: 301226) with a closing price of 30.08, down 4.81% [2] - Sanxie Electric (Code: 920100) with a closing price of 62.22, down 3.65% [2] - Jiangte Electric (Code: 002176) with a closing price of 9.22, down 2.23% [2] Capital Flow - The electric motor sector saw a net outflow of 380 million yuan from institutional investors, while retail investors contributed a net inflow of 347 million yuan [2][3] - Key stocks with significant capital flow included: - Jiangsu Leili (Code: 300660) with a net inflow of 13.51 million yuan from institutional investors [3] - Jiadian Co., Ltd. (Code: 000922) with a net inflow of 10.77 million yuan from institutional investors [3] - Keli'er (Code: 002892) with a net inflow of 9.92 million yuan from institutional investors [3]